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Abstract Elevated cardiac troponin I (cTnI), a marker for
cardiac damage, has been reported after high-intensity
exercise in healthy subjects. Currently, little is known about
the impact of prolonged moderate-intensity exercise on
cTnI release, but also the impact of obesity on this
response. 97 volunteers (55 men and 42 women), stratiWed
for BMI, performed a single bout of walking exercise
(30–50 km). We examined cTnI-levels before and immedi-
ately after the exercise bout in lean (BMI < 25 kg/m2,
n = 30, 57 § 19 years), overweight (25 · BMI < 30 kg/m2,
n = 29, 56 § 11 years), and obese subjects (BMI ¸ 30 kg/
m2, n =2 8 ,  5 3§ 9 years). Walking was performed at a self-
selected pace. cTnI was assessed using a high-sensitive
cTnI-assay (Centaur; clinical cut-oV value ¸0.04 g/L).
We recorded subject characteristics (body weight, blood
pressure, presence of cardiovascular risk) and examined
exercise intensity by recording heart rate. Mean cTnI-levels
increased signiWcantly from 0.010 § 0.006 to 0.024 §
0.046 g/L (P < 0.001). The exercise-induced increase in
cTnI was not diVerent between lean, overweight and obese
subjects (two-way ANOVA interaction; P = 0.27). In 11
participants, cTnI was elevated above the clinical cut-oV
value for myocardial infarction. Logistic regression analysis
identiWed exercise intensity (P < 0.001), but not BMI, body
fat percentage or waist circumference to signiWcantly relate
to positive troponin tests. In conclusion, prolonged, moder-
ate-intensity exercise results in a comparable increase in
cTnI-levels in lean, overweight and obese subjects. There-
fore, measures of obesity unlikely relate to the magnitude
of the post-exercise elevation in cTnI.
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Introduction
The presence of intracellular cardiac troponin subunits T
and I (cTnT and cTnI) in the blood is a sensitive and spe-
ciWc indicator for myocardial injury (Thygesen et al. 2007;
Wu 2009), whilst elevated cTn levels play a central role in
the diagnosis of acute myocardial infarction (AMI) (Kra-
gelj et al. 2000; Thygesen et al. 2007). Previous studies
have also reported release of circulating cTnT/cTnI concen-
trations after prolonged exercise, with cTn levels even
exceeding the cut-oV level typically used for the diagnosis
of AMI (Eijsvogels et al. 2010; Koller 2003; Neumayr et al.
2005; Shave et al. 2007a,  2010; Whyte et al. 2007; Wu
2009).
Previous studies indicated that cardiovascular risk fac-
tors are associated with higher baseline cTn-levels under
resting conditions (Wallace et al. 2006). Interestingly,
recent clinical and epidemiological studies have demon-
strated that these elevated resting cTn levels are predictive
of all-cause mortality (Daniels et al. 2008; de Lemos et al.
2010; Saunders et al. 2011) and future cardiovascular dis-
ease (Daniels et al. 2008; Everett et al. 2011; Saunders
et al. 2011) in the selected patient groups as well as in the
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general population. If cTnI levels are higher at baseline,
cTnI levels may rise even more under demanding condi-
tions such as exercise. Therefore, subjects with increased
cardiovascular risk may demonstrate a larger exercise-
induced increase in cTnI compared to healthy controls.
Obesity represents an important and common cardiovas-
cular risk factor (Gelber et al. 2008), whilst the prevalence
of obesity is still rising (across all ages) and aVecting both
the developed and developing world (James 2008). Some
previous studies found that measures of obesity, such as
body mass index, may be associated with higher resting
cTn-levels in the general public (de Lemos et al. 2010;
Saunders et al. 2011). However, it is currently unknown
whether obesity alters the exercise-induced troponin
release. This is of special importance as exercise training is
routinely prescribed as an eVective strategy to lose weight
to individuals with obesity. Therefore, we assessed the
eVect of obesity on cardiac troponin release after prolonged
moderate-intensity exercise. We measured cTnI concentra-
tions in lean, overweight and obese subjects with compara-
ble training status before and immediately after a single
bout of prolonged exercise. For this purpose, we examined
changes in absolute cTnI-levels, identiWed those with an
elevation in cTnI above the cut-oV value for acute myocar-
dial infarction, and examined whether these post-exercise
cTnI-levels were related to obesity or to other individual or
exercise-related factors. We hypothesize to Wnd higher cTnI
levels in obese compared to overweight and lean subjects.
Methods
Subjects
Ninety-seven participants were included and stratiWed for
body mass index (BMI), as this measure is frequently used
and widely adopted to deWne overweight/obesity. Subjects
were deWned as lean (BMI < 25, n = 30), overweight
(25 · BMI < 30,  n = 29) or obese (BMI ¸ 30 kg/m2,
n = 28) and were allocated to walk 30, 40 or 50 km
(Table 1). In addition, we also assessed body fat percentage
and waist circumference as alternative markers of over-
weight/obesity. Written informed consent was obtained
from all participants prior to the start of the study. This
study was approved by the Medical Ethical Committee of
the Radboud University Nijmegen Medical Centre, and was
conducted in accordance with the Declaration of Helsinki.
Experimental design
Subjects participated in the International Nijmegen Four
Days Marches, an annual walking event in The Nether-
lands, and walked 30 km (30%), 40 km (47%) or 50 km
(23%) at a self selected pace. 12–36 h prior to the start of
the march, baseline measurements (subject characteristics,
health and training status) were conducted under controlled
conditions. 15 min prior to the exercise bout, heart rate and
core body temperature were measured. During exercise,
heart rate and core body temperature were measured every
subsequent 5 km. Immediately after Wnishing, all measure-
ments were repeated.
Measurements
Subject characteristics
At baseline, body mass (Seca 888 scale, Hamburg, Ger-
many) and height were measured in duplicate and BMI was
calculated. A four-point skinfold thickness measurement
(biceps, triceps, sub-scapular, supra-iliac) was obtained by
a well-trained and highly experienced researcher to calcu-
late the body fat percentage (Durnin and Womersley 1974).
Waist circumference was measured midway between the
lower rib margin and iliac crest. Hip circumference was
measured at the level of widest circumference over the
greater trochanters. Waist to-hip ratio was calculated as
waist circumference divided by hip circumference. Resting
heart rate and blood pressure were measured twice using an
automated sphygmomanometer (M5-1 intellisense, Omron
Healthcare, Hoofddorp, The Netherlands) after 5-min
seated rest. Finally, all subjects completed a questionnaire
about their physical activity (hours of sport participation
per week), training status (walking-speciWc training history
in the year preceding the walking march) and health status
(presence of pathology and use of medication).
Core body temperature
Core body temperature was assessed using a portable
telemetry system (CorTemp™ system, HQ Inc, Palmetto,
USA), which has been demonstrated to be safe and reliable
(Byrne and Lim 2007; Gant et al. 2006). Participants
ingested an individually calibrated telemetric temperature
sensor the evening preceding the experiment. Prior to the
start of the exercise, core body temperature of each individ-
ual participant was measured using an external recorder.
Baseline core body temperature was deWned as the average
of three consecutive measurements within 30 s. Similarly,
core body temperature was measured at every 5 km point
during the march. The highest value of these measurements
was presented as maximum core body temperature.
Exercise intensity
Heart rate was measured with a two-channel ECG chest band
system (Polar Electro Oy, Kempele, Finland) simultaneouslyEur J Appl Physiol (2012) 112:1725–1732 1727
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with core body temperature (i.e. every 5 km point, 3 con-
secutive measurements which were taken within 30 s),
using the same data recorder. Mean heart rate during exer-
cise was calculated as the average heart rate, excluding the
values derived directly before the start and after the Wnish.
Exercise intensity was calculated by dividing the mean
heart rate during exercise by the maximal predicted heart
rate (208–0.7 age) (Tanaka et al. 2001). Subsequently,
exercise intensity was presented as a percentage of maxi-
mal heart rate (%HRmax).
Blood analysis
Ten ml of venous blood were drawn from an antecubital
vein at baseline and directly after Wnishing. Whole venous
blood was collected in serum-gel vacutainer tubes and
allowed to clot for »45 min. After centrifugation, serum
was aliquoted, frozen and stored at ¡80°C for later analy-
sis. Analysis was performed on a single day using the same
calibration and set-up to minimize variation. cTnI was
analysed using a highly-sensitive cTnI-assay (Centaur
TnI-Ultra, Siemens Healthcare Diagnostics, Breda, The
Netherlands). The assay imprecision of the highly-sensitive
cTnI-assay was 5.3% at 0.08 g/L and 3.0% at 27.2 g/L.
A cTnI-value of 0.04 g/L is the clinical cut-oV value for
myocardial infarction (Apple et al. 2008).
Ambient conditions
Throughout the experiment, dry bulb, wet bulb, and globe
temperatures were measured every 30 min using a portable
climate monitoring device (Davis instruments inc.,
Table 1 Subject characteristics and details about the health status, presented per subgroup
a, b Post-hoc signiWcant diVerence in relation to lean and overweight subjects respectively
c Ln-transformation was applied as a non-Gaussian distribution was present
BMI < 25 25 · BMI < 30 BMI ¸ 30 P value
Demographic characteristics
Sex (men:women) 15:15 15:14 25:13 –
Age (years) 57 § 19 56 § 11 53 § 90 . 5 3
Height (cm) 174 § 11 174 § 91 7 5 § 90 . 8 4
Weight (kg) 69.5 § 11.2 83.5 § 8.1a 101.4 § 10.7a,b <0.001
Body-mass index (kg/m2) 22.8 § 1.9 27.4 § 1.4a 32.9 § 1.9a,b <0.001
Waist circumference (cm) 93 § 61 0 2 § 6a 111 § 7a,b <0.001
Waist to hip ratio 0.91 § 0.07 0.95 § 0.06 0.99 § 0.07a,b <0.001
Body fat (%) 29 § 63 4 § 6a 38 § 6a,b <0.001
Glucose (mmol/L) 5.4 § 1.3 5.4 § 0.5 5.7 § 1.4 0.41
Cholesterol (mmol/L) 5.3 § 1.1 5.4 § 1.1 5.5 § 1.1 0.85
Triglycerides (mmol/L) 1.1 § 0.6 1.5 § 0.6a 1.5 § 0.8a 0.07
High density lipoproteins (mmol/L) 1.5 § 0.3 1.2 § 0.2a 1.2 § 0.3a 0.001
Low density lipoproteins (mmol/L) 3.3 § 0.9 3.6 § 1.0 3.6 § 1.0 0.54
Health status
Mean distance trained (km/year)c 578 § 651 452 § 715 633 § 587 0.54
Mean arterial pressure (mm Hg) 98 § 11 104 § 11 107 § 13a 0.011
Use of prescribed medicines (%) 47 62 82a 0.010
Diuretics (%) 3 3 16 0.10
Anti-hypertensive drugs (%) 13 24 37 0.09
Statins (%) 10 10 16 0.71
Beta-blockers (%) 7 7 13 0.57
Anti-diabetic drugs (%) 3 0 11 0.13
Pathology (%) 53 72 68 0.26
Hypertension (%) 20 24 37 0.27
Hypercholesterolemia (%) 13 10 21 0.45
Skin disease (%) 7 24 16 0.18
Osteoporosis (%) 10 10 5 0.69
Asthma (%) 3 14 16 0.24
Diabetes (%) 3 0 11 0.131728 Eur J Appl Physiol (2012) 112:1725–1732
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Hayward, USA) positioned at the start/Wnish area. The wet
bulb globe temperature index (WBGT) was calculated using
the formula: WBGT = 0.1 (Tdry bulb) + 0.7 (Twet bulb)+0 . 2
(Tglobe) (Armstrong et al. 2007).
Statistical analysis
All values were presented as mean § standard deviation,
unless indicated otherwise. Statistical analyses were per-
formed using SPSS 16.0 (SPSS, Chicago, IL, USA). The
level of statistical signiWcance was set at P <0 . 0 5 .
The normality of the data distribution was examined by the
Kolmogorov–Smirnov test. When data demonstrated a
non-Gaussian distribution, Ln-transformation was applied.
Comparisons between groups were assessed using a one-
way ANOVA for continuously distributed data. A two-way
repeated measures ANOVA was applied to examine the
change in cTnI after exercise in the three distinct groups
(exercise £ group). Post hoc t tests with the Least Square
DiVerence correction for multiple comparisons were per-
formed when the ANOVA reported a signiWcant main or
interaction eVect. A backward stepwise linear regression
analysis was used to identify factors that signiWcantly relate
to post-exercise cTnI-levels. We have included BMI, age,
sex, exercise intensity and pre-existing cardiovascular
pathology as potential determinants of post-exercise cTnI-
levels as previous studies have demonstrated evidence that
these factors may relate to exercise-induced cTnI release
(Eijsvogels et al. 2010; Shave et al. 2007b). In addition, we
replaced BMI with two alternative measures of obesity (fat
percentage and waist circumference) in the regression anal-
ysis to further assess the eVect of obesity on post-exercise
cTnI levels. Finally, using the same sets of parameters, a
binary logistic regression analysis was used to identify fac-
tors that contribute to the positive cTnI-samples
(cTn > URL). The odds ratio (OR) and 95% conWdence
interval (CI) were presented for those factors that were
identiWed as signiWcant factors to contribute to a positive
cTnI-sample.
Results
The three BMI groups were not diVerent in age and height,
but as expected diVered signiWcantly in weight, BMI, body
surface area, waist circumference and body fat percentage
(Table 1). Participation in sports activities and the distance
trained was not diVerent across groups (Table 1), but the
average training distance of 560 km suggested that our sub-
jects were well prepared for the walking march. No diVer-
ences in the prevalence of (cardiovascular) pathology were
found (Table 1). Obese subjects, however, showed a higher
mean arterial pressure and used more prescribed medica-
tion than their lean counterparts (Table 1).
Exercise characteristics
All subjects successfully completed the exercise bout. The
WBGT increased from 14.0°C in the morning to a maxi-
mum of 25.0°C in the afternoon. Walking speed did not sig-
niWcantly diVer across groups (Table 2). Baseline and
maximum core body temperature during exercise were not
diVerent between lean, overweight, and obese subjects,
whilst also exercise intensity (%HRmax) was comparable
across groups (Table 2).
Cardiac troponin
Ln-transformation was applied to the cTnI data set, as a
non-Gaussian distribution was found. Baseline cTnI levels
were not diVerent across the three groups. The two-way
ANOVA revealed a signiWcant increase in cTnI from
0.010 § 0.006 to 0.024 § 0.046 g/L after exercise
(P < 0.001) (Fig. 1). However, the magnitude of the exer-
cise-induced increase in cTnI in lean (pre: 0.009 § 0.007,
post: 0.014 § 0.010 g/L) was not diVerent from overweight
(pre: 0.012 § 0.008, post: 0.040 § 0.085 g/L) or obese
subjects (pre: 0.009 § 0.005, post: 0.021 § 0.016 g/L)
(Fig. 1). To gain further insight into factors that contribute
to cTnI-release, a backward linear regression analysis
Table 2 Exercise characteris-
tics per BMI group
BMI < 25 25 · BMI < 30 BMI ¸ 30 P value
Exercise characteristics
Walking distance 0.87
30 (km) 34 34 24
40 (km) 43 45 52
50 (km) 23 21 24
Exercise duration (hh:mm) 8:32 § 1:58 8:39 § 1:25 8:48 § 1:23 0.79
Speed (km/h) 4.8 § 0.7 4.7 § 0.8 4.7 § 0.7 0.69
Baseline core body temperature (°C) 37.5 § 0.4 37.6 § 0.5 37.5 § 0.3 0.55
Maximum core body temperature (°C) 38.3 § 0.3 38.4 § 0.3 38.5 § 0.3 0.053
Exercise intensity (% HRmax)7 1 § 97 1 § 10 74 § 80 . 3 0
P value refers to a One-Way 
ANOVAEur J Appl Physiol (2012) 112:1725–1732 1729
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identiWed age ( =0 . 2 7 ,   P = 0.003), sex ( = ¡0.19,
P = 0.031) and exercise intensity (%HRmax,   =0 . 4 7 ,
P < 0.001, Fig. 2), but not BMI and pre-existing cardiovas-
cular pathology, as signiWcant predictors of post-exercise
cTnI-level (r2 =0 . 3 8 ,   P < 0.001). Using fat percentage as a
marker for obesity, we identiWed the same predictor vari-
ables with a comparable total predicted variance (r2 =0 . 3 6 ,
P < 0.001). Also using waist circumference we found the
same total predicted variance (r2 =0 . 3 8 ,  P < 0.001), and
conWrmed the predictive capacity of age ( =0 . 3 1 ,
P < 0.001) and exercise intensity (%HRmax,   =0 . 4 3 ,
P < 0.001). However, waist circumference ( =0 . 2 2 ,
P < 0.01) replaced sex as a signiWcant predictor.
Eleven of our participants (9 male, 2 female) showed a
cTnI level above the AMI cut-oV (cTn > URL). A Chi-
square test revealed that the presence of cTn > URL
diVered between lean, overweight and obese subjects
(n = 0, 7 and 4, respectively, P = 0.014). However, subjects
with cTnI < ULR and cTnI > URL did not diVer in age,
BMI, fat percentage or waist circumference (corrected for
sex) or presence of diseases (i.e. hypertension, hypercholes-
terolemia and diabetes), whilst exercise intensity was sig-
niWcantly higher in subjects with cTn > URL (Table 3).
Using binary logistic regression analysis, we found that
exercise intensity (%HRmax, P < 0.01, OR = 1.1, CI: 1.0–
1.3) was associated with a cTn > URL. This Wnding was
present, independent of using BMI, fat percentage or waist
circumference as a measure of obesity in our model.
Discussion
This is the Wrst study, to our knowledge, to directly exam-
ine the impact of obesity on cTnI-release during prolonged
exercise. Our results indicate that prolonged moderate-
intensity walking exercise signiWcantly elevates cTnI-levels
in asymptomatic subjects. More importantly, and in con-
trast to our hypothesis, the magnitude of the absolute cTnI-
increase was comparable between lean, overweight, and
obese subjects. When using the cTnI cut-oV level for diag-
nosis of AMI (Thygesen et al. 2007), 11% of our asymp-
tomatic participants demonstrated a positive test.
Nonetheless, our statistical analysis revealed that these pos-
itive cTnI tests could not be explained through measures of
obesity (BMI, body fat percentage or waist circumference).
Analysis of cTnI is recommended as a sensitive and
speciWc marker for cardiac damage in the diagnosis of
AMI (Morrow et al. 2007; Thygesen et al. 2007; Wu 2009).
Fig. 1 Pre- (black bars) and post-exercise (white bars) cTnI levels in
lean (BMI < 25 kg/m2,  n = 30), overweight (25 · BMI < 30 kg/m2,
n = 29) and obese subjects (BMI ¸ 30 kg/m2, n = 38). Two-way RM
ANOVA revealed a signiWcant time (P < 0.001) and group (P = 0.033)
eVect. However, no interaction was present (time £ group, P = 0.27)
which indicates that the exercise-induced increase in cTnI was not
signiWcantly diVerent across groups. Error bars represent SE
Fig. 2 Correlation between exercise intensity (expressed as percent-
age of maximum predicted heart rate) and Ln-transformed cardiac
troponin I levels (cTnI). An increase in exercise intensity is signiW-
cantly related to higher levels of cTnI (P < 0.001, r = 0.48)
Table 3 Subject characteristics and cardiovascular risk factors in sub-
jects with a cTnI level below (cTn < URL) and above (cTn > URL) the
clinical cut-oV value for AMI
A students T Test (continuous parameters) and a Chi Square test
(binominal parameters) were used to compare cTn < URL with
cTn > URL
cTn < URL cTn > URL P value
Sex (men:women) 46:40 9:2 0.074
Age (yr) 55 § 14 54 § 80 . 7 8
Body-mass index (kg/m2) 28.0 § 4.7 29.4 § 3.9 0.32
Fat percentage (%) 34 § 73 4 § 60 . 8 4
Waist circumference (mm) 97 § 13 105 § 11 0.13
Exercise intensity (%) 71 § 98 0 § 90 . 0 0 3
Use of prescribed medicines (%) 67 45 0.15
Hypertension (%) 29 18 0.45
Hypercholesterolemia (%) 17 0 0.13
Diabetes (%) 6 0 0.41
Smoking (%) 7 18 0.211730 Eur J Appl Physiol (2012) 112:1725–1732
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The observation that cTnI-levels were elevated after exer-
cise in lean, overweight and obese subjects, with even 11%
of our population (n = 11) exceeding the cut-oV value for
AMI, is highly clinically relevant. Whilst previous studies
predominantly focused on cTnI-levels in athletes after
high-intensity exercise (Dawson et al. 2008; George et al.
2004; Middleton et al. 2008; Scharhag et al. 2005), we
showed that prolonged moderate-intensity walking exercise
(72% of the maximal predicted heart rate) can lead to sig-
niWcant elevations of post-exercise cTnI in a heterogeneous
group of asymptomatic humans.
We found that the exercise-induced increase in cTnI is
comparable between lean, overweight, and obese subjects.
This suggests that, in contrast to our hypothesis, obesity
does not aVect the magnitude of post-exercise cTnI eleva-
tion. Indeed, linear regression analysis using various mea-
sures of obesity (i.e. BMI, fat percentage and waist
circumference) identiWed that exercise intensity, age and
sex signiWcantly contribute to the post-exercise cTnI level.
Although one of the models replaced sex with waist cir-
cumference, this Wnding may be confounded by the co-line-
arity between these measures. In addition, 9 of the 11
subjects with cTnI-levels above the clinical cut-oV value
were men who typically demonstrate a larger waist circum-
ference than women. Furthermore, we demonstrated that
BMI, body fat percentage, and waist circumference were
not diVerent between subjects with and without a positive
cTnI test, whilst the binary logistic regression analysis
identiWed exercise intensity as a predictor of a positive cTnI
sample. Taken together, our data suggests that obesity
unlikely contributes to the magnitude of the post-exercise
elevation in cTnI.
Although obesity may not alter the magnitude of the
exercise-induced increase in cTnI, our observation does not
necessarily invalidate the hypothesis that subjects with car-
diovascular risk may demonstrate a larger exercise-induced
increase in cTnI. Indeed, we identiWed advanced age and
male sex, i.e. both well-established cardiovascular risk fac-
tors, as independent predictors for the magnitude of the
exercise-induced increase in cTnI. Interestingly, a recent
multivariable regression analysis identiWed age and sex, but
also fasting glucose and NT-proBNP, as signiWcant predic-
tors for resting cTnT in the general community (Xu et al.
2011). This provides indirect support for the above hypoth-
esis. In addition, since we performed this study, there is
evolving evidence that cardiovascular risk factors than
obesity (e.g. diabetes mellitus and hypertension) have a
more profound eVect on resting cTn-levels (deFilippi et al.
2010; Xu et al. 2011). Unfortunately, due to the selection
criteria for our study, subgroups with diabetes and/or car-
diovascular risk in our study are too small to perform mean-
ingful statistical analysis. We strongly support future
studies to examine whether other cardiovascular risk
factors than obesity inXuence the exercise-induced eleva-
tion in cTn.
Elevated cTnI levels are suggestive for cardiac damage,
but the average cTnI increase in our study was small and
was not associated with symptoms of cardiac injury. It may
well be possible that the increase in cTnI did not reXect
irreversible ischemic myocardial “damage”, but relates to a
physiological response during prolonged exercise. The ele-
vated heart rate during exercise may cause an increased
mechanical stress on the heart, possibly leading to an
increased release of cTnI. Interestingly, our study identiWed
exercise intensity as the strongest predictor for the increase
of cTnI levels, but also for a positive cTnI test. Exercise
intensity, and the associated increased myocardial work,
may therefore contribute to cTnI-release during prolonged
moderate-intensity exercise. These Wndings are in agree-
ment with a recent paper that found that exercise intensity
inXuenced the magnitude of the troponin response during
marathon running (Legaz-Arrese et al. 2011). Moreover,
the increased myocardial work can also transiently acceler-
ate the constant process of apoptosis and regeneration in
the myocardium (Beltrami et al. 2003). The very small
amounts of cardiac ‘damage’ are subsequently repaired as
part of the normal regenerative capacity of the myocar-
dium, but would also cause a temporal increase in cTnI lev-
els post-exercise. A last explanation relates to an impaired
clearance of troponin from the circulation. Blood Xow in
the abdominal area and kidneys reduces markedly during
exercise (Qamar and Read 1987; Suzuki et al. 1996; Thijs-
sen et al. 2009). Consequently, the kidneys capacity to
secrete substances is attenuated (Suzuki et al. 1996), possi-
bly resulting in a small increase in cTnI concentration in the
blood.
Limitations
The strengths of this study are the inclusion of a large group
of participants, the unique study design and completion of a
prolonged exercise bout. Due to practical limitations, we
did not determine maximal heart rate, but used a previously
validated and frequently used model to predict maximal
heart rate (Tanaka et al. 2001). A limitation is our single
post-exercise assessment of cTnI, as previous observations
reported a time-dependent change in cTnI after a marathon
(Middleton et al. 2008). It is currently unknown whether
obesity alters the time-course of cTnI-release after exercise
and, therefore, potentially alters our Wndings. In addition, it
must be noted the coeYcient of variation increases when
measuring at the lower end of the cTnI spectrum. However,
excluding subjects with low values (i.e. below 0.006 g/L)
did not alter the major outcomes of our study.
In conclusion, prolonged exercise resulted in a signiW-
cant increase in cTnI-levels in asymptomatic lean, over-Eur J Appl Physiol (2012) 112:1725–1732 1731
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weight, and obese subjects. The magnitude of the exercise-
induced increase in cTnI was not diVerent among lean,
obese, and overweight subjects and relates predominantly
to age, gender and exercise intensity. These Wndings were
reinforced by our subjects with a cTnI above the clinical
cut-oV level, as their BMI, fat percentage and waist circum-
ference was comparable with subjects below this level.
Therefore, obesity unlikely contributes to the magnitude of
the post-exercise elevation in cTnI.
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